Short-term effect of polyethylene glycol loxenatide on weight loss in overweight or obese patients with type 2 diabetes: an open-label, parallel-arm, randomized, metformin-controlled trial

HIGHLIGHTS

• who: Hongyu Cai et al. from the Beijing of Chinese Medicine, China have published the paper: Short-term effect of polyethylene glycol loxenatide on weight loss in overweight or obese patients with type 2 diabetes: An open-label, parallel-arm, randomized, metformin-controlled trial, in the Journal: (JOURNAL)
• what: The main reasons for withdrawal were AEs and failure to follow-up . In the present trial, compared with metformin treatment, the addition of PEG-Loxe with lifestyle interventions or OAD therapy resulted in significantly greater weight loss at week 16.
• how: The following information . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.